STOCK TITAN
  1. Home
  2. News
  3. RWLK

Rewalk Robotics Ltd - RWLK STOCK NEWS

Welcome to our dedicated news page for Rewalk Robotics (Ticker: RWLK), a resource for investors and traders seeking the latest updates and insights on Rewalk Robotics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Rewalk Robotics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Rewalk Robotics's position in the market.

News
VA STAND Act introduced in the United States Senate
Rhea-AI Summary
ReWalk Robotics (DBA Lifeward™), a global leader in assistive technologies, applauds the introduction of a Senate companion bill to H.R. 6373, the VA Spinal Trauma Access to New Devices (STAND) Act. The legislation aims to provide annual examinations and assessments for assistive technologies, including Personal Exoskeletons, for Veterans with Spinal Cord Injury, increasing access to life-changing solutions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.29%
Tags
none
-
News
Lifeward Announces Reverse Share Split
Rhea-AI Summary
ReWalk Robotics Ltd. (LFWD) announces a 1-for-7 reverse split to meet Nasdaq listing standards. The split aims to increase share price above $1.00 while reducing outstanding shares. The split will apply to warrants and stock options, with issued shares decreasing from 60.1 million to 8.6 million post-split.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.5%
Tags
stock split
-
News
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
Rhea-AI Summary
Two recent research publications highlight the effectiveness of the ReStore Exo-Suit in improving walking ability for post-stroke patients. The studies show significant improvements in walking speed and distance, emphasizing the clinical value of Lifeward's technology for rehabilitation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.9%
Tags
none
News
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: LFWD) announced a deferral in pricing decision for personal exoskeletons by CMS, with payment determination on a case-by-case basis until finalized. Lifeward has provided 35 exoskeletons to Medicare beneficiaries to support demand.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.29%
Tags
none
-
News
Lifeward Reports Fourth Quarter and Full Year 2023 Financial Results
Rhea-AI Summary
ReWalk Robotics Ltd. (DBA Lifeward) reported record annual revenue of $13.9 million in 2023, a 151% increase from 2022. The integration of commercial and operational resources led to $3 million in annual net savings. The company unveiled its new branding as Lifeward and benefitted from CMS including exoskeletons in the Medicare brace benefit category. Fourth-quarter revenue was $6.9 million, up 216% from 2022, with a gross margin of 35.5%. Operating expenses were $8.6 million, resulting in an operating loss of $6.1 million. Net loss was $5.6 million. The company had $28.1 million in cash and expects 2024 revenue between $28 to $32 million.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
earnings
-
News
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: LFWD) to release fourth quarter and fiscal year-end 2023 financial results on February 27, 2024. Conference call with CEO and CFO to discuss financial results. Webcast available on GoLifeward.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.44%
Tags
conferences earnings
News
ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
Rhea-AI Summary
ReWalk Robotics Ltd. rebrands as Lifeward, unveiling a new name, stock ticker, logo, website, and corporate messaging. The company aims to empower individuals facing physical limitations or disabilities by delivering innovative solutions like the AlterG Anti-Gravity systems. The rebrand reflects the broader goal of elevating the standard of care in rehabilitation and driving growth through a unified commercial team. The new stock ticker 'LFWD' will be effective from January 30, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.06%
Tags
none
-
News
ReWalk Robotics Expands Direct Sales Coverage to Canada
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: RWLK) is expanding its direct sales coverage to Canada following the integration of the former ReWalk and AlterG commercial teams. The company anticipates increased sales force capacity and plans to penetrate underserved markets with its innovative technologies for individuals with neurological conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.85%
Tags
none
-
News
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: RWLK) will present at the Sidoti January Virtual Investor Conference on January 17-18, 2024. CEO Larry Jasinski and CFO Mike Lawless will provide an overview presentation and host one-on-one meetings with investors. Interested investors can register for the presentation or one-on-ones at www.sidoti.com/events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.85%
Tags
conferences
News
First ReWalk Personal Exoskeleton Claim Paid by Medicare
Rhea-AI Summary
ReWalk Robotics Ltd. (Nasdaq: RWLK) announced that it has received payment from Noridian Healthcare Solutions for its first claim for the ReWalk Personal Exoskeleton, marking coverage and payment by Medicare fee-for-service for the first-ever claim submitted for a ReWalk Personal Exoskeleton device. This milestone reflects an acknowledgement by Medicare that the ReWalk Personal Exoskeleton is a medically necessary device, as supported by a body of scientific evidence, when prescribed for an eligible Medicare beneficiary with spinal cord injury. The 2024 Home Health Rule, which codifies a clear coverage pathway for personal exoskeletons, has gone into effect on January 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.57%
Tags
none
Stock RWLK logo
Rewalk Robotics Ltd

Nasdaq:RWLK

RWLK Rankings

N/A Ranked by Market Cap
#4143 Ranked by Stock Gains
N/A Ranked by Dividends

RWLK Stock Data

8.92M
58.82M
1.96%
20.72%
2.27%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
Israel
P O Box 161

About RWLK

exoskeleton leader rewalk robotics, inc. (formerly argo medical technologies) develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury (sci). rewalk’s mission is to fundamentally change the health and life experiences of individuals with spinal cord injury. founded in 2001, rewalk has headquarters in the us, israel and germany. rewalk robotics' rewalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with spinal cord injury (sci) to stand upright and walk. rewalk is the only exoskeleton with fda clearance via clinical studies and extensive performance testing for personal use rewalk has been tested extensively in the u.s., europe, and israel. the rewalk system is supported by the most published data of all exoskeleton systems in the rehabilitation market, and is used by more people worldwide than all other exoskeleton systems combined. the company offers two products: rewalk personal and the